Thor Medical ASA (OSL:TRMED)
Norway · Delayed Price · Currency is NOK 6.91
+0.22 (3.29%)
Aug 24, 2026, 4:28 PM CET
Thor Medical ASA Market Cap
Thor Medical ASA has a market cap or net worth of 2.49 billion as of August 24, 2026. Its market cap has increased by 159.09% in one year.
Market Cap
2.49B
Enterprise Value
2.48B
Revenue
839.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
6.91
ChartMarket Cap Chart
Since July 4, 2023, Thor Medical ASA's market cap has increased from 466.61M to 2.49B, an increase of 433.12%. That is a compound annual growth rate of 70.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 2.49B | 33.82% |
| Dec 30, 2025 | 1.86B | 151.99% |
| Dec 30, 2024 | 737.69M | 144.87% |
| Dec 29, 2023 | 301.27M | -35.44% |
| Jul 4, 2023 | 466.61M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Circio Holding ASA | 2.19B |
| Nykode Therapeutics AS | 1.47B |
| ArcticZymes Technologies ASA | 1.06B |
| Zelluna ASA | 655.93M |
| Lytix Biopharma ASA | 576.75M |
| Oncoinvent ASA | 372.60M |
| SoftOx Solutions AS | 226.36M |
| Aqua Bio Technology ASA | 77.43M |